29 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
for the Management ... Task Force on Clinical ... #HeartFailure #Management ... #ACCAHA2017 #cardiology ... #treatment #algorithm
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff Guidelines ... - Table 1. ... Recommendations for the Treatment ... of Clostridium ... Infection in Adults #Management
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff Guidelines ... - Table 2. ... Recommendations for the Treatment ... of Clostridium ... in Children #Management
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff Guidelines ... - Table 7. ... Potential Treatment ... Agents for Treatment ... #Pharmacology #Management
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Practice Guideline ... for the Management ... with ‘treatment ... Personality #Disorder #Medications ... Effectiveness #Table
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology #treatment ... #medications #table ... #decisionaid #cardiology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... #Pharmacology #Management ... #Treatment #StageC ... #Cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Dosing: 250 mcg tablet ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication ... won’t have any clinical
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... via AHA/ACC/HRS Guidelines ... #Management #Pharm ... #EM #IM #Cardiology ... #Afib #Common #Medications
Natural history
Aneurysms may progress in size as a result of gradual wall weakening [6], with rupture
Table 1: Annual ... References: Radiology ... et al. (2003) Guidelines ... for the treatment ... 37:1106-1117 #Management